247 related articles for article (PubMed ID: 17222411)
1. Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor.
Kaneko MK; Kato Y; Kameyama A; Ito H; Kuno A; Hirabayashi J; Kubota T; Amano K; Chiba Y; Hasegawa Y; Sasagawa I; Mishima K; Narimatsu H
FEBS Lett; 2007 Jan; 581(2):331-6. PubMed ID: 17222411
[TBL] [Abstract][Full Text] [Related]
2. LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin.
Kato Y; Ogasawara S; Oki H; Goichberg P; Honma R; Fujii Y; Kaneko MK
PLoS One; 2016; 11(3):e0152912. PubMed ID: 27031228
[TBL] [Abstract][Full Text] [Related]
3. Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor.
Kaneko MK; Kato Y; Kitano T; Osawa M
Gene; 2006 Aug; 378():52-7. PubMed ID: 16766141
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
[TBL] [Abstract][Full Text] [Related]
5. Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells.
Kaneko M; Kato Y; Kunita A; Fujita N; Tsuruo T; Osawa M
J Biol Chem; 2004 Sep; 279(37):38838-43. PubMed ID: 15231832
[TBL] [Abstract][Full Text] [Related]
6. Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin.
Ogasawara S; Oki H; Kaneko MK; Hozumi Y; Liu X; Honma R; Fujii Y; Nakamura T; Goto K; Takagi M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):318-26. PubMed ID: 26492619
[TBL] [Abstract][Full Text] [Related]
7. Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle.
Nilsson J; Nilsson J; Larson G; Grahn A
Glycobiology; 2010 Sep; 20(9):1160-9. PubMed ID: 20507882
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific and site directed N-glycosylation pattern of FcγRIIIa.
Zeck A; Pohlentz G; Schlothauer T; Peter-Katalinić J; Regula JT
J Proteome Res; 2011 Jul; 10(7):3031-9. PubMed ID: 21561106
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.
Engelmann K; Kinlough CL; Müller S; Razawi H; Baldus SE; Hughey RP; Hanisch FG
Glycobiology; 2005 Nov; 15(11):1111-24. PubMed ID: 15972891
[TBL] [Abstract][Full Text] [Related]
11. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
Wong NS; Yap MG; Wang DI
Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
[TBL] [Abstract][Full Text] [Related]
12. Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2.
Ogasawara S; Kaneko MK; Price JE; Kato Y
Hybridoma (Larchmt); 2008 Aug; 27(4):259-67. PubMed ID: 18707544
[TBL] [Abstract][Full Text] [Related]
13. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin.
Oki H; Ogasawara S; Kaneko MK; Takagi M; Yamauchi M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):44-50. PubMed ID: 25723283
[TBL] [Abstract][Full Text] [Related]
15. A novel strategy for mammalian cell surface glycome profiling using lectin microarray.
Tateno H; Uchiyama N; Kuno A; Togayachi A; Sato T; Narimatsu H; Hirabayashi J
Glycobiology; 2007 Oct; 17(10):1138-46. PubMed ID: 17693441
[TBL] [Abstract][Full Text] [Related]
16. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.
Jongen SP; Gerwig GJ; Leeflang BR; Koles K; Mannesse ML; van Berkel PH; Pieper FR; Kroos MA; Reuser AJ; Zhou Q; Jin X; Zhang K; Edmunds T; Kamerling JP
Glycobiology; 2007 Jun; 17(6):600-19. PubMed ID: 17293352
[TBL] [Abstract][Full Text] [Related]
17. Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis.
Sekiguchi T; Takemoto A; Takagi S; Takatori K; Sato S; Takami M; Fujita N
Oncotarget; 2016 Jan; 7(4):3934-46. PubMed ID: 26684030
[TBL] [Abstract][Full Text] [Related]
18. Application of lectin microarray to crude samples: differential glycan profiling of lec mutants.
Ebe Y; Kuno A; Uchiyama N; Koseki-Kuno S; Yamada M; Sato T; Narimatsu H; Hirabayashi J
J Biochem; 2006 Mar; 139(3):323-7. PubMed ID: 16567396
[TBL] [Abstract][Full Text] [Related]
19. Identification of N-glycosylated proteins from the central nervous system of Drosophila melanogaster.
Koles K; Lim JM; Aoki K; Porterfield M; Tiemeyer M; Wells L; Panin V
Glycobiology; 2007 Dec; 17(12):1388-403. PubMed ID: 17893096
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric determination of the sites of O-glycan attachment with low picomolar sensitivity.
Rademaker GJ; Pergantis SA; Blok-Tip L; Langridge JI; Kleen A; Thomas-Oates JE
Anal Biochem; 1998 Mar; 257(2):149-60. PubMed ID: 9514784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
